Agteria funding news – Stockholm-based Agteria Biotech Raises €6Million in Seed Funding
Feb 12, 2025 | By Kailee Rainse

Stockholm-based Agteria Biotech, focused on reducing global greenhouse gas emissions by 1%, has raised €6M in seed funding. The round was co-led by Industrifonden and AgriZeroNZ, with support from Norrsken Launcher and Mudcake.
SUMMARY
- Stockholm-based Agteria Biotech, focused on reducing global greenhouse gas emissions by 1%, has raised €6M in seed funding.
- Agteria Biotech was founded in 2023 by Martin Blomberg, Dr. Tommi Remonen, and Maia Lidbeck.
Mala Valroy, Investment Manager at Industrifonden, says, “Agteria’s progress in a short time is remarkable, driven by a small, highly ambitious, and energetic team. We’re excited to support their journey as they bring a unique, scalable, science-backed innovation with the potential to significantly reduce agricultural greenhouse gas emission.”
RECOMMENDED FOR YOU

ZYMVOL funding news – Spanish Biotech Startup ZYMVOL Secures €3 Million in Seed Funding
Kailee Rainse
Feb 20, 2025

Genesy funding news – Barelona-based Genesy raises €5 Million in Seed Funding
Kailee Rainse
Jan 14, 2025
Wayne McNee, Chief Executive at AgriZeroNZ, adds, “We’re actively scanning the world for innovative ventures to invest in to help farmers reduce emissions. We’re proud to back Agteria to accelerate the development of a practical, effective solution suitable for grazing systems in New Zealand and around the world.”
Before this round, in March 2024, Agteria Biotech raised €1.4M in a pre-seed funding round led by Norrsken Launcher.
It says that methane is a major cause of climate change, being 28 times more harmful than carbon dioxide and contributing to 30% of global warming. Reducing methane emissions, especially from cattle, which make up 5% of global greenhouse gases, has become a top priority.
Read also - Pixel Photonics funding news – Munster-based DeepTech Startup Pixel Photonics Secures €1 Million in Funding
The €6M investment shows that investors recognize the urgency of this issue. The funding will help Agteria move closer to getting regulatory approval for its methane-reducing products for cattle, with a focus on safety for animals, consumers, and the environment.
Martin Blomberg, CEO of Agteria Biotech, says, “Our goal from the start has been to create a solution that is not only effective but also scalable, affordable, and, above all, safe. Methane levels in the atmosphere have never been higher, in 2024 global temperatures surpassed 1.5 degrees for the first time, and reducing methane is the most impactful short-term action we can take to combat warming. Together with our new investors, combining deep tech experience and strong market knowledge we are ready to accelerate this critical work.”
About Agteria Biotech
Agteria Biotech was founded in 2023 by Martin Blomberg, Dr. Tommi Remonen, and Maia Lidbeck. The company has created a patent-pending molecule that reduces methane emissions from cattle. This solution is scalable, affordable, and provides the best methane reduction for the cost. It has been tested in several trials and is attracting interest from the beef, dairy, and animal feed industries.
Agteria is moving forward with a science-based, team-oriented approach. By working with experts and conducting thorough studies, the company is speeding up the process of getting regulatory approval.